We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
288 hedge funds and large institutions have $5.34B invested in Intra-Cellular Therapies Inc. in 2023 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 115 increasing their positions, 78 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
55% more call options, than puts
Call options by funds: $16.6M | Put options by funds: $10.7M
47% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 78
42% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 36
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
18% more capital invested
Capital invested by funds: $4.55B → $5.34B (+$797M)
5% more funds holding
Funds holding: 274 → 288 (+14)
Holders
288
Holders Change
+14
Holders Change %
+5.11%
% of All Funds
4.52%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.17%
New
51
Increased
115
Reduced
78
Closed
36
Calls
$16.6M
Puts
$10.7M
Net Calls
+$5.94M
Net Calls Change
-$34M
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$207M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$62M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.1M |
| 4 |
DM
Deerfield Management
New York
|
-$39.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$36.7M |
